VOR (STOCKS)
Vor Biopharma Inc. Common Stock
$14.330000
-0.030000 (-0.21%)
Prev close: $14.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jean-Paul Kress
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $762.40M
- Employees
- 168
- P/E (TTM)
- -0.04
- P/B (TTM)
- -5.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-5.11 | $-0.79 | -4.3218 | -548.31% |
|
Dec 2025 (Q4)
|
$25.84 | $-1.69 | +27.5341 | +1,625.29% |
|
Sep 2025 (Q3)
|
$-3.33 | $-3.28 | -0.0455 | -1.39% |
|
Jun 2025 (Q2)
|
$-43.80 | $-8.86 | -34.9443 | -394.60% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$509.57M |
| Operating Expenses | $373.51M |
| Research and Development | $312.43M |
| Other Operating Expenses | $61.09M |
| Operating Income/Loss | -$373.51M |
| Income/Loss From Continuing Operations After Tax | -$883.08M |
| Income/Loss From Continuing Operations Before Tax | -$883.08M |
| Net Income/Loss | -$883.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$883.08M |
| Net Income/Loss Available To Common Stockholders, Basic | -$883.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $168.31 |
| Diluted Earnings Per Share | $168.31 |
| Basic Average Shares | 178,439,530 |
| Diluted Average Shares | 178,439,530 |
| Assets | $506.75M |
| Current Assets | $500.78M |
| Cash | $491.50M |
| Prepaid Expenses | $6.39M |
| Other Current Assets | $2.88M |
| Noncurrent Assets | $5.97M |
| Fixed Assets | $565.00K |
| Other Non-current Assets | $5.40M |
| Liabilities | $657.17M |
| Current Liabilities | $16.08M |
| Accounts Payable | $1.04M |
| Wages | $2.23M |
| Other Current Liabilities | $12.81M |
| Noncurrent Liabilities | $641.09M |
| Equity | -$150.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$150.42M |
| Liabilities And Equity | $506.75M |
| Net Cash Flow From Operating Activities | -$149.89M |
| Net Cash Flow From Operating Activities, Continuing | -$149.89M |
| Net Cash Flow From Investing Activities | -$311.81M |
| Net Cash Flow From Investing Activities, Continuing | -$311.81M |
| Net Cash Flow From Financing Activities | $579.28M |
| Net Cash Flow From Financing Activities, Continuing | $579.28M |
| Net Cash Flow | $117.58M |
| Net Cash Flow, Continuing | $117.58M |
| Comprehensive Income/Loss | -$883.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$883.81M |
| Other Comprehensive Income/Loss | -$813.40M |
| Other Comprehensive Income/Loss Attributable To Parent | -$729.00K |